Francesco Galimi

Technik-/Wissenschafts-/F&E-Leiter bei ADICET BIO, INC.

Vermögen: 147 611 $ am 31.05.2024

56 Jahre

Health Technology

Consumer Services

Aktive Positionen von Francesco Galimi

Unternehmen	Position	Beginn	Ende
ADICET BIO, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2019	-
Adicet Therapeutics, Inc. Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2019	-

Unternehmen	Position	Beginn	Ende
AMGEN INC.	Corporate Officer/Principal	01.01.2015	01.01.2019
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Corporate Officer/Principal	01.01.2014	01.01.2015
ADICET BIO, INC.	Technik-/Wissenschafts-/F&E-Leiter	15.09.2020	-

University of Turin

Doctorate Degree

International

Vereinigte Staaten	6
Italien	2

Operativ

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Health Technology	6
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
ADICET BIO, INC.	Health Technology
AMGEN INC.	Health Technology

Private Unternehmen	3
resTORbio, Inc. resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.	Health Technology
Adicet Therapeutics, Inc. Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA.	Health Technology
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Health Technology